Fresenius Offers First And Only Canadian Tocilizumab Biosimilar

Kabi’s Tyenne Once Again Takes Pole Position Among Actemra Rivals

 
• By Dave Wallace
  
Kabi is first to launch a biosimilar tocilizumab in Canada (Shutterstock)

More from Biosimilars

More from Generics Bulletin